Sinovac files new drug application for hand, foot and mouth EV71 vaccine

3 June 2013 / By Tim / Emerging Markets, Featured on App, R&D, Regulation and Policy / 0 comments

Sinovac Biotech announced that the new drug application (NDA) for its ED71 vaccine has been filed and accepted by the Beijing Drug Administration. The Beijing [...]

More in Emerging Markets

New vaccine developed for Hand, Foot and Mouth Disease in China

29 May 2013 / By Tim / Emerging Markets, Featured on App, Prophylactic Vaccines, R&D / 0 comments
India announces development of $1 rotavirus vaccine

15 May 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 1 comment
Takeda acquires Inviragen and their DENVax vaccine

8 May 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 0 comments
What role do you see the developing world taking in relation to vaccine development?

1 May 2013 / By Tim / Emerging Markets, Featured on App / 0 comments
Download: Implementing Rapid Flu Vaccine Production Facing a Pandemic Threat

8 April 2013 / By jolene / Emerging Markets, Flu, Uncategorized / 0 comments
Sanofi plans China growth with 4 new plants

4 April 2013 / By Tim / Emerging Markets, Featured on App / 0 comments
Download Presentation: H5N1 & Seasonal Influenza in Indonesia

4 April 2013 / By jolene / Emerging Markets, Flu / 0 comments
Pharma going global needs to think local in emerging markets

2 April 2013 / By Tim / Emerging Markets, Featured on App / 0 comments
Guest bloggers for World Vaccine Congress Washington 2013

26 March 2013 / By Freya Smale / Emerging Markets, Featured on App, Flu, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines, Veterinary Vaccines / 0 comments
Study highlights lack of VC funding in emerging markets

19 March 2013 / By Tim / Emerging Markets, Featured on App / 0 comments